Procurement Biopsies in the Evaluation of Deceased Donor Kidneys

Biopsies taken at deceased donor kidney procurement continue to be cited as a leading reason for discard; however, the reproducibility and prognostic capability of these biopsies are controversial. We compiled a retrospective, single-institution, continuous cohort of deceased donor kidney transplant...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical journal of the American Society of Nephrology 2018-12, Vol.13 (12), p.1876-1885
Hauptverfasser: Carpenter, Dustin, Husain, S Ali, Brennan, Corey, Batal, Ibrahim, Hall, Isaac E, Santoriello, Dominick, Rosen, Raphael, Crew, R John, Campenot, Eric, Dube, Geoffrey K, Radhakrishnan, Jai, Stokes, M Barry, Sandoval, P Rodrigo, D'Agati, Vivette, Cohen, David J, Ratner, Lloyd E, Markowitz, Glen, Mohan, Sumit
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Biopsies taken at deceased donor kidney procurement continue to be cited as a leading reason for discard; however, the reproducibility and prognostic capability of these biopsies are controversial. We compiled a retrospective, single-institution, continuous cohort of deceased donor kidney transplants performed from 2006 to 2009. Procurement biopsy information-percentage of glomerulosclerosis, interstitial fibrosis/tubular atrophy, and vascular disease-was obtained from the national transplant database. Using univariable, multivariable, and time-to-event analyses for death-censored graft survival, we compared procurement frozen section biopsy reports with reperfusion paraffin-embedded biopsies read by trained kidney pathologists ( =270). We also examined agreement for sequential procurement biopsies performed on the same kidney ( =116 kidneys). For kidneys on which more than one procurement biopsy was performed ( =116), category agreement was found in only 64% of cases ( =0.14). For all kidneys ( =270), correlation between procurement and reperfusion biopsies was poor: overall, biopsies were classified into the same category (optimal versus suboptimal) in only 64% of cases ( =0.25). This discrepancy was most pronounced when categorizing percentage of glomerulosclerosis, which had 63% agreement ( =0.15). Interstitial fibrosis/tubular atrophy and vascular disease had agreement rates of 82% ( =0.13) and 80% ( =0.15), respectively. Ninety-eight (36%) recipients died, and 56 (21%) allografts failed by the end of follow-up. Reperfusion biopsies were more prognostic than procurement biopsies (hazard ratio for graft failure, 2.02; 95% confidence interval, 1.09 to 3.74 versus hazard ratio for graft failure, 1.30; 95% confidence interval, 0.61 to 2.76), with procurement biopsies not significantly associated with graft failure. We found that procurement biopsies are poorly reproducible, do not correlate well with paraffin-embedded reperfusion biopsies, and are not significantly associated with transplant outcomes.
ISSN:1555-9041
1555-905X
DOI:10.2215/CJN.04150418